COc1cccc([C@H]2Oc3ccc(OC)cc3/C(=N\OCC[C@@H]3C=C[C@H](OC(C)=O)[C@H](COC(C)=O)O3)[C@@H]2O)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?